Potassium Ion

Potassium Ion

SCHEMBL1998222

CC(C)(c1ccccc1)c1cc(Br)c(OP(=O)([O-])Oc2c(Br)cc(C(C)(C)c3ccccc3)cc2Br)c(Br)c1.[K+]

nearest known ligand 0.40

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

AGTR1DHFRGABBR1GABBR2GABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGARTNR3C2PBP2XPTGS1PTGS2VKORC1blablaT-3blaT-4blaT-5blaT-6dacAdacBdacCfolAftsImrcAmrcBmrdApbp1apbp1bpbp2apbp2bpbp3polthyA

The experimentally established mechanism targets of Potassium Ion. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NR3C2 known ✓ P08235 3/20 0.36
GPR84 Q9NQS5 4/20 0.40
CYP1A2 P05177 1/20 0.37
CYP2C19 P33261 1/20 0.37
ALDH1A1 P00352 3/20 0.36
CYP3A4 P08684 2/20 0.36
ALOX15 P16050 2/20 0.36
ALOX12 P18054 2/20 0.36
HPGD P15428 1/20 0.36
TSHR P16473 1/20 0.36
CASP1 P29466 1/20 0.36
RECQL P46063 1/20 0.36
HIF1A Q16665 1/20 0.36
HSD17B10 Q99714 1/20 0.36
TDP1 Q9NUW8 1/20 0.36
ESR1 P03372 1/20 0.35
ESR2 Q92731 1/20 0.35
CNR1 P21554 2/20 0.33
CNR2 P34972 2/20 0.33
PTPN1 P18031 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1898991 0.84 ALDH1A1 (0.41) GPR84CYP1A2CYP2C19ALDH1A1CYP3A4
SCHEMBL27746631 0.82 ALDH1A1 (0.40) CYP1A2CYP2C19ALDH1A1CYP3A4ALOX15
Lithium Ion SCHEMBL4623871 0.73 GPR84 (0.46) GPR84ALDH1A1CYP3A4TDP1NR3C2
SCHEMBL1995047 0.73 GPR84 (0.50) GPR84ALDH1A1CYP3A4TDP1NR3C2
Potassium Ion SCHEMBL1996218 0.71 GPR84 (0.40) GPR84CYP3A4ALOX15ALOX12TSHR
SCHEMBL8623383 0.69 CYP3A4 (0.76) CYP1A2CYP2C19ALDH1A1CYP3A4ALOX15
SCHEMBL28716953 0.69 CNR1 (0.49) CYP2C19ALDH1A1CYP3A4ALOX15ALOX12
SCHEMBL1262667 0.68 MEN1 (0.64) CYP1A2ALDH1A1CYP3A4ALOX15ALOX12
SCHEMBL6939817 0.67 MAPT (0.50) ALDH1A1CYP3A4ALOX15ALOX12HPGD
SCHEMBL6854492 0.67 ESR1 (0.61) ALDH1A1CYP3A4ALOX15HPGDTSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 33 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4474426-A1 POLYCARBONATE-BASED RESIN COMPOSITION AND MOLDED OBJECT Kaneka Corporation (JP) 2024-12-11 EP disclosed
CN-118574893-A Polycarbonate resin composition and molded article 株式会社钟化 2024-08-30 CN disclosed
WO-2023234367-A1 POLYCARBONATE RESIN COMPOSITION AND SHAPED ARTICLE 株式会社カネカ 2023-12-07 WO disclosed
WO-2023149409-A1 POLYCARBONATE-BASED RESIN COMPOSITION AND MOLDED OBJECT 株式会社カネカ 2023-08-10 WO disclosed
EP-3056488-A1 BISBENZOXAZINONE COMPOUND Teijin Chemicals, Ltd. (JP) 2016-08-17 EP disclosed
EP-2505585-B1 BIS-BENZOXAZINONE COMPOUND TEIJIN CHEMICALS LTD (JP) 2016-08-03 EP disclosed
US-8969436-B2 Method of producing a molded article TEIJIN CHEMICALS, LTD. (JP) 2015-03-03 US disclosed
US-8697788-B2 Polycarbonate resin composition and molded article thereof TEIJIN CHEMICALS, LTD. (JP) 2014-04-15 US disclosed
US-20120252941-A1 BISBENZOXAZINONE COMPOUND TEIJIN CHEMICALS, LTD. (JP) 2012-10-04 US disclosed
EP-2505585-A1 BIS-BENZOXAZINONE COMPOUND Teijin Chemicals, Ltd. (JP) 2012-10-03 EP disclosed
US-20050119441-A1 Copolycarbonate and heat-resistant part comprising the copolymer TEIJIN CHEMICALS LTD. (JP) 2005-06-02 US disclosed
EP-1038920-B1 RESIN COMPOSITION TEIJIN CHEMICALS LTD (JP) 2004-12-15 EP disclosed
US-6780917-B2 MOLDING MATERIALS; MIXTURE CONTAINING FILLER TEIJIN CHEMICALS, LTD. (JP) 2004-08-24 US disclosed
US-20040152806-A1 Polycarbonate resin composition, pellets thereof and molded article thereof TEIJIN CHEMICALS LTD. (JP) 2004-08-05 US disclosed
US-20040014851-A1 Polycarbonate-based molding material and optical disk substrates TEIJIN CHEMICALS LTD. (JP) 2004-01-22 US disclosed
EP-1300445-A1 AROMATIC POLYCARBONATE RESIN COMPOSITION Teijin Chemicals, Ltd. (JP) 2003-04-09 EP disclosed
US-20030004251-A1 Aromatic polycarbonate resin composition TEIJIN CHEMICALS LTD. (JP) 2003-01-02 US disclosed
US-6362269-B1 BLEND OF AROMATIC POLYCARBONATE AND STYRENE POLYMER OR AROMATIC POLYESTER TEIJIN CHEMICALS, LTD. (JP) 2002-03-26 US disclosed
US-6355767-B1 BLEND WITH THERMOPLASTIC GRAFT POLYMER COMPRISING VINYL CYANIDE, VINYLAROMATIC AND DIENE COMONOMERS; HEAT RESISTANCE, TRANSPARENCY, NONHYDROLYZING, IMPACT STRENGTH TEIJIN CHEMICALS, LTD (JP) 2002-03-12 US disclosed
EP-1038920-A1 RESIN COMPOSITION Teijin Chemicals, Ltd. (JP) 2000-09-27 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120252941-A1 BISBENZOXAZINONE COMPOUND RPS4Y1, RPS4X, H1-4 NR3C2 350/4885GPR84 2802/4885CYP1A2 847/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.